According to our latest report, entitled “Indian Diagnostic Market Analysis”, despite being privileged by well-structured and standardized healthcare industry, India’s diagnostics sector is largely fragmented and the organized sector contributes only 10% of the total market. However, the share of the organized sector in total market is likely to reach 50% in the coming decade. With the value of around INR 116 Billion (US$ 2.4 Billion) in 2010, the Indian diagnostics market is witnessing a period of strong demand patterns and huge investments.
We have found that Molecular Diagnostics segment is gradually emerging as the fastest growing segment in the diagnostics industry. Molecular diagnostic tests have been proved beneficial for the predictive diagnosis of individuals with onset of diseases like breast cancer using specific gene mutations. These tests have other important applications also that make them an attractive segment. Among all the application areas, infectious disease segment holds the largest share in the molecular diagnostics sector.
The report, “Indian Diagnostic Market Analysis”, covers almost all the key aspects of market and investigates trends that are likely to impact the industry in the long run. The report also provides a cost analysis patterns taking into account the affordability factor and health insurance. It also presents a concrete picture of the regulatory environment in the market and discusses the key developments.
The report is an outcome of an extensive research and in-depth analysis of the Indian diagnostics market that takes into account the data reliability and proper content flow. The report investigates the current market trends and identifies the ones that will have a crucial impact on the market development. Overall, the report is likely to prove beneficial for clients and investors concerned with the Indian diagnostics market.
For more information visit: http://www.rncos.com/Report/IM242.htm |
